Skip to content

13F-HR filed by CAXTON CORP

CAXTON CORP filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-14, with 16 holding rows worth $98,249,000.

Accession
0000919574-17-007834
Filed
2017-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2017

A holdings report, 16 entries on the cover page, a total value of $98,249,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $98,249,000 with VALUE read as thousands by filing date, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD5,514,994$38,053,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
SPY78462F103SHS77,052$19,358,000thousands by filing dateputThe filing omitted confidential holdings, a later amendment may add them.
KALA BIO INC COM483119103Stock544,220$12,430,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
AGILE THERAPEUTICS INC00847L100COM1,820,012$8,117,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
GARRISON CAP INC366554103COM850,000$7,166,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
MOLECULAR TEMPLATES INC608550109COM1,013,787$7,066,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
Berkshire Hathaway Inc084670702COM8,945$1,640,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
JBG SMITH PPTYS COM46590V100REIT36,129$1,236,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
INTEC PHARMA LTD JERUSALEMM53644106SHS76,139$681,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
CM FIN INC COM12574Q103COM61,429$574,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
GTX INC DEL40052B207COM NEW62,869$531,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
ADIENT PLCG0084W101ORD SHS4,737$398,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
TEAM HEALTH HOLDINGS INC87817A107COMMON STOCK7,709$335,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock1,997$306,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
ACLARIS THERAPEUTICS INC COM00461U105Stock10,176$263,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
MARINUS PHARMACEUTICALS INC56854Q101COM16,198$95,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-17-007834this filing2017-11-14acceptance time not in the bulk data set